Total Payments
$6,182
2024 Payments
$2,575
Companies
37
Transactions
336
Medicare Patients
3,032
Medicare Billing
$334,650
Payment Breakdown by Category
Food & Beverage$6,169 (99.8%)
Other$12.43 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,169 | 335 | 99.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12.43 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,461 | 123 | $0 (2024) |
| UCB, Inc. | $901.80 | 39 | $0 (2024) |
| MDD US Operations, LLC | $677.93 | 12 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $321.47 | 19 | $0 (2021) |
| SK Life Science, Inc. | $220.88 | 8 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $216.47 | 12 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $206.89 | 9 | $0 (2022) |
| Eisai Inc. | $188.14 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $176.26 | 11 | $0 (2024) |
| ARGENX US, INC. | $163.44 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,575 | 97 | MDD US Operations, LLC ($591.56) |
| 2023 | $1,299 | 63 | ABBVIE INC. ($374.09) |
| 2022 | $894.27 | 60 | ABBVIE INC. ($256.66) |
| 2021 | $1,081 | 96 | Biohaven Pharmaceuticals, Inc. ($309.51) |
| 2020 | $211.92 | 13 | Novartis Pharmaceuticals Corporation ($47.20) |
| 2018 | $11.76 | 1 | Supernus Pharmaceuticals, Inc. ($11.76) |
| 2017 | $109.22 | 6 | Supernus Pharmaceuticals, Inc. ($50.16) |
All Payment Transactions
336 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Musculoskeletal | ||||||
| 12/13/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: Neurology | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Neurology | ||||||
| 11/25/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $29.61 | General |
| Category: Neurology | ||||||
| 11/22/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $30.75 | General |
| 11/22/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/15/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Neurology | ||||||
| 11/14/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Neuropsychiatry | ||||||
| 11/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.68 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: EPILEPSY | ||||||
| 11/07/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: Neurology | ||||||
| 10/31/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Neurology | ||||||
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: PAIN | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Neuropsychiatry | ||||||
| 10/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Neurology | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: EPILEPSY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 675 | 782 | $231,616 | $85,004 |
| 2022 | 7 | 742 | 911 | $222,971 | $83,623 |
| 2021 | 6 | 772 | 927 | $209,075 | $79,457 |
| 2020 | 9 | 843 | 3,774 | $225,039 | $86,566 |
Total Patients
3,032
Total Services
6,394
Medicare Billing
$334,650
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 139 | 153 | $83,385 | $32,667 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 178 | 216 | $57,672 | $21,056 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 227 | 279 | $53,010 | $17,025 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $15,930 | $5,691 | 35.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 52 | 52 | $12,324 | $4,271 | 34.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 19 | 22 | $2,860 | $2,166 | 75.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $6,435 | $2,128 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 273 | 376 | $71,754 | $25,396 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 159 | 210 | $56,965 | $20,281 | 35.6% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 76 | 81 | $44,145 | $17,471 | 39.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 107 | 107 | $25,359 | $9,158 | 36.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 60 | 70 | $9,100 | $5,370 | 59.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $13,098 | $4,472 | 34.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 30 | 30 | $2,550 | $1,476 | 57.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 243 | 297 | $80,680 | $30,020 | 37.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 327 | 421 | $79,501 | $28,823 | 36.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 63 | 63 | $22,296 | $8,830 | 39.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 81 | 81 | $19,183 | $6,409 | 33.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 37 | 42 | $5,460 | $3,880 | 71.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 21 | 23 | $1,955 | $1,496 | 76.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 405 | 583 | $90,983 | $33,524 | 36.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 172 | 204 | $46,564 | $16,986 | 36.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 17 | 2,731 | $32,772 | $13,053 | 39.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 110 | 110 | $25,300 | $9,127 | 36.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 58 | 63 | $5,355 | $3,989 | 74.5% |
About Dr. Eric Kramer, MD
Dr. Eric Kramer, MD is a Neurology healthcare provider based in Atlantis, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801866587.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Kramer, MD has received a total of $6,182 in payments from pharmaceutical and medical device companies, with $2,575 received in 2024. These payments were reported across 336 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,169).
As a Medicare-enrolled provider, Kramer has provided services to 3,032 Medicare beneficiaries, totaling 6,394 services with total Medicare billing of $334,650. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Atlantis, FL
- Active Since 01/25/2006
- Last Updated 10/04/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1801866587
Products in Payments
- Briviact (Drug) $820.63
- NURTEC ODT (Drug) $680.35
- BOTOX (Biological) $672.22
- Apokyn (Drug) $591.56
- UBRELVY (Drug) $349.30
- QULIPTA (Drug) $289.00
- DUOPA (Drug) $239.13
- INGREZZA (Drug) $177.48
- Leqembi (Drug) $167.23
- REXULTI (Drug) $159.60
- AIMOVIG (Biological) $128.03
- VYVGART HYTRULO (Drug) $113.30
- TROKENDI XR (Drug) $101.51
- VYEPTI (Biological) $98.06
- Aimovig (Biological) $94.95
- APOKYN (Drug) $86.37
- NOURIANZ (Drug) $84.90
- HYQVIA (Biological) $81.76
- AMYVID (Drug) $70.41
- Austedo XR (Drug) $57.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Atlantis
Mark Goldstein, Md, MD
Neurology — Payments: $241,679
Neurology $241,679
Jose Labault-Santiago, M.d, M.D
Neurology — Payments: $8,889
Neurology $8,889
Teresita Casanova, M.d, M.D
Neurology — Payments: $8,760
Neurology $8,760
Casandra Mateo, M.d, M.D
Neurology — Payments: $8,571
Neurology $8,571
James Goldenberg, Md, MD
Neurology — Payments: $1,012
Neurology $1,012
Dr. Yvonne Jurcik, M.d, M.D
Neurology — Payments: $134.36
Neurology $134.36